India’s drug regulator grants Gilead Sciences marketing authorization for remdesivir

US pharma giant Gilead Sciences received marketing authorization by India’s drug regulator for its antiviral drug remdesivir for “restricted emergency use” on hospitalized COVID-19 patients.

Read More


Sources